<p><strong>EyePoint, Inc.</strong> (NASDAQ:EYPT) 的股东们会很高兴地看到，股价在过去一个月表现出色，上涨了 38%，并从之前的疲软中恢复过来。上个月的表现为过去一年 103% 的大幅增长画上了句号。</p>
<p>在价格大幅反弹后，EyePoint 的市销率（&#34;P/S&#34;）为 31.5 倍，与美国制药行业的其他公司相比，可能看起来像是一个强烈的卖出信号，因为大约一半的公司市销率低于 4.1 倍，甚至低于 1.3 倍的市销率也相当普遍。不过，仅仅将市销率表面化是不明智的，因为可能有解释说明其如此高的原因。</p>
<p>特朗普承诺要&#34;释放&#34;美国的石油和天然气，这 15 只美国股票的发展有望受益。</p>
<p>查看我们对 EyePoint 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/4481199-ps-multiple-vs-industry-1-dark-2/1765563441809?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/4481199-ps-multiple-vs-industry-1-dark-2/1765563441809"/></p>
<p>NasdaqGM:EYPT 市销率与行业比较 2025 年 12 月 12 日</p>
<h3>EyePoint 的市销率对股东意味着什么？</h3>
<p>最近，EyePoint 的表现不佳，其收入下降与其他公司相比显得相当糟糕，后者的收入平均有所增长。一个可能性是，市销率之所以高，是因为投资者认为这种糟糕的收入表现将会好转。如果没有，那么现有股东可能会对股价的可行性感到极度紧张。</p>
<p>如果您想了解分析师对未来的预测，您应该查看我们关于 EyePoint 的 <strong>免费</strong> 报告。</p>
<h2>收入预测是否与高市销率相匹配？</h2>
<p>EyePoint 的市销率对于一家预计将实现非常强劲增长的公司来说是典型的，重要的是，其表现将远超行业水平。</p>
<p>回顾过去一年，该公司的收入出现了令人沮丧的 7.4% 的下降。这抹去了过去三年中的任何增长，总体上几乎没有实现收入的变化。因此，可以公平地说，该公司的收入增长最近一直不稳定。</p>
<p>展望未来，预计未来三年将实现每年 72% 的增长，这是由观察该公司的十二位分析师估算的。这一增长预计将显著高于更广泛行业的 28% 的年增长率。</p>
<p>考虑到这一点，理解为什么 EyePoint 的市销率相对于其行业同行如此之高并不困难。似乎大多数投资者都在期待这种强劲的未来增长，并愿意为该股票支付更高的价格。</p>
<h2>关键要点</h2>
<p>强劲的股价飙升导致 EyePoint 的市销率也随之飙升。通常情况下，我们会警惕在做出投资决策时过度解读市销率，尽管它可以揭示其他市场参与者对公司的看法。</p>
<p>我们对 EyePoint 的分析显示，其市销率仍然高于其强劲的未来收入的合理性。股东们似乎对公司的未来收入充满信心，这支撑了市销率。除非这些条件发生变化，否则它们将继续为股价提供强有力的支持。</p>
<p>在您采取下一步之前，您应该了解我们发现的 <strong>EyePoint 的 3 个警告信号</strong>。</p>
<p>当然，<strong>盈利能力强且有良好盈利增长历史的公司通常是更安全的投资</strong>。因此，您可能希望查看这份 <strong>免费</strong> 的其他公司集合，这些公司具有合理的市盈率并且盈利增长强劲。</p>
<p>国防与灾难的移动基础设施</p>
<p>下一波机器人技术不是类人型的。它是完全自主的塔楼，在 30 分钟内提供 5G、ISR 和雷达服务，随时随地。</p>
<p>在下一轮合同之前获取投资者简报</p>
<p>由 CiTech 赞助</p>

EYPT

<p>EyePoint, Inc.（纳斯达克代码：EYPT）的股价最近上涨了 38%，使其在过去一年中上涨了 103%。尽管其市销率为 31.5 倍，远高于行业同行，但投资者对未来增长持乐观态度，预计未来三年年均增长将达到 72%。这种乐观情绪支撑了当前的股价，尽管最近收入有所下降。分析师建议保持谨慎，指出高市销率反映了对未来收入的强烈预期</p>

<p><strong>EyePoint, Inc.</strong> (NASDAQ:EYPT) shareholders would be excited to see that the share price has had a great month, posting a 38% gain and recovering from prior weakness. The last month tops off a massive increase of 103% in the last year.</p>
<div class="lb-trans"><p><strong>EyePoint, Inc.</strong> (NASDAQ:EYPT) 的股东们会很高兴地看到，股价在过去一个月表现出色，上涨了 38%，并从之前的疲软中恢复过来。上个月的表现为过去一年 103% 的大幅增长画上了句号。</p>
</div><p>Following the firm bounce in price, EyePoint's price-to-sales (or &#34;P/S&#34;) ratio of 31.5x might make it look like a strong sell right now compared to other companies in the Pharmaceuticals industry in the United States, where around half of the companies have P/S ratios below 4.1x and even P/S below 1.3x are quite common. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's so lofty.</p>
<div class="lb-trans"><p>在价格大幅反弹后，EyePoint 的市销率（&#34;P/S&#34;）为 31.5 倍，与美国制药行业的其他公司相比，可能看起来像是一个强烈的卖出信号，因为大约一半的公司市销率低于 4.1 倍，甚至低于 1.3 倍的市销率也相当普遍。不过，仅仅将市销率表面化是不明智的，因为可能有解释说明其如此高的原因。</p>
</div><p>Trump has pledged to &#34;unleash&#34; American oil and gas and these 15 US stocks have developments that are poised to benefit.</p>
<div class="lb-trans"><p>特朗普承诺要&#34;释放&#34;美国的石油和天然气，这 15 只美国股票的发展有望受益。</p>
</div><p>Check out our latest analysis for EyePoint</p>
<div class="lb-trans"><p>查看我们对 EyePoint 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/4481199-ps-multiple-vs-industry-1-dark-2/1765563441809" alt="" original-src="https://images.simplywall.st/asset/chart/4481199-ps-multiple-vs-industry-1-dark-2/1765563441809"/></p>
<p>NasdaqGM:EYPT Price to Sales Ratio vs Industry December 12th 2025</p>
<div class="lb-trans"><p>NasdaqGM:EYPT 市销率与行业比较 2025 年 12 月 12 日</p>
</div><h3>What Does EyePoint's P/S Mean For Shareholders?</h3>
<div class="lb-trans"><h3>EyePoint 的市销率对股东意味着什么？</h3>
</div><p>EyePoint hasn't been tracking well recently as its declining revenue compares poorly to other companies, which have seen some growth in their revenues on average. One possibility is that the P/S ratio is high because investors think this poor revenue performance will turn the corner. If not, then existing shareholders may be extremely nervous about the viability of the share price.</p>
<div class="lb-trans"><p>最近，EyePoint 的表现不佳，其收入下降与其他公司相比显得相当糟糕，后者的收入平均有所增长。一个可能性是，市销率之所以高，是因为投资者认为这种糟糕的收入表现将会好转。如果没有，那么现有股东可能会对股价的可行性感到极度紧张。</p>
</div><p>If you'd like to see what analysts are forecasting going forward, you should check out our <strong>free</strong> report on EyePoint.</p>
<div class="lb-trans"><p>如果您想了解分析师对未来的预测，您应该查看我们关于 EyePoint 的 <strong>免费</strong> 报告。</p>
</div><h2>Do Revenue Forecasts Match The High P/S Ratio?</h2>
<div class="lb-trans"><h2>收入预测是否与高市销率相匹配？</h2>
</div><p>EyePoint's P/S ratio would be typical for a company that's expected to deliver very strong growth, and importantly, perform much better than the industry.</p>
<div class="lb-trans"><p>EyePoint 的市销率对于一家预计将实现非常强劲增长的公司来说是典型的，重要的是，其表现将远超行业水平。</p>
</div><p>Retrospectively, the last year delivered a frustrating 7.4% decrease to the company's top line. This has erased any of its gains during the last three years, with practically no change in revenue being achieved in total. Therefore, it's fair to say that revenue growth has been inconsistent recently for the company.</p>
<div class="lb-trans"><p>回顾过去一年，该公司的收入出现了令人沮丧的 7.4% 的下降。这抹去了过去三年中的任何增长，总体上几乎没有实现收入的变化。因此，可以公平地说，该公司的收入增长最近一直不稳定。</p>
</div><p>Turning to the outlook, the next three years should generate growth of 72% per annum as estimated by the twelve analysts watching the company. That's shaping up to be materially higher than the 28% per annum growth forecast for the broader industry.</p>
<div class="lb-trans"><p>展望未来，预计未来三年将实现每年 72% 的增长，这是由观察该公司的十二位分析师估算的。这一增长预计将显著高于更广泛行业的 28% 的年增长率。</p>
</div><p>With this in mind, it's not hard to understand why EyePoint's P/S is high relative to its industry peers. It seems most investors are expecting this strong future growth and are willing to pay more for the stock.</p>
<div class="lb-trans"><p>考虑到这一点，理解为什么 EyePoint 的市销率相对于其行业同行如此之高并不困难。似乎大多数投资者都在期待这种强劲的未来增长，并愿意为该股票支付更高的价格。</p>
</div><h2>The Key Takeaway</h2>
<div class="lb-trans"><h2>关键要点</h2>
</div><p>The strong share price surge has lead to EyePoint's P/S soaring as well. Typically, we'd caution against reading too much into price-to-sales ratios when settling on investment decisions, though it can reveal plenty about what other market participants think about the company.</p>
<div class="lb-trans"><p>强劲的股价飙升导致 EyePoint 的市销率也随之飙升。通常情况下，我们会警惕在做出投资决策时过度解读市销率，尽管它可以揭示其他市场参与者对公司的看法。</p>
</div><p>Our look into EyePoint shows that its P/S ratio remains high on the merit of its strong future revenues. It appears that shareholders are confident in the company's future revenues, which is propping up the P/S. Unless these conditions change, they will continue to provide strong support to the share price.</p>
<div class="lb-trans"><p>我们对 EyePoint 的分析显示，其市销率仍然高于其强劲的未来收入的合理性。股东们似乎对公司的未来收入充满信心，这支撑了市销率。除非这些条件发生变化，否则它们将继续为股价提供强有力的支持。</p>
</div><p>Before you take the next step, you should know about the <strong>3 warning signs for EyePoint</strong> that we have uncovered.</p>
<div class="lb-trans"><p>在您采取下一步之前，您应该了解我们发现的 <strong>EyePoint 的 3 个警告信号</strong>。</p>
</div><p>Of course, <strong>profitable companies with a history of great earnings growth are generally safer bets</strong>. So you may wish to see this <strong>free</strong> collection of other companies that have reasonable P/E ratios and have grown earnings strongly.</p>
<div class="lb-trans"><p>当然，<strong>盈利能力强且有良好盈利增长历史的公司通常是更安全的投资</strong>。因此，您可能希望查看这份 <strong>免费</strong> 的其他公司集合，这些公司具有合理的市盈率并且盈利增长强劲。</p>
</div><p>Mobile Infrastructure for Defense and Disaster</p>
<div class="lb-trans"><p>国防与灾难的移动基础设施</p>
</div><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p>
<div class="lb-trans"><p>下一波机器人技术不是类人型的。它是完全自主的塔楼，在 30 分钟内提供 5G、ISR 和雷达服务，随时随地。</p>
</div><p>Get the investor briefing before the next round of contracts</p>
<div class="lb-trans"><p>在下一轮合同之前获取投资者简报</p>
</div><p>Sponsored On Behalf of CiTech</p>
<div class="lb-trans"><p>由 CiTech 赞助</p>
</div>

EyePoint 公司（NASDAQ:EYPT）的股票在上涨 38% 后并未被市场忽视